Diagnosis of Osteoporosis in Multiple Myeloma: Current Approaches and Perspectives
DOI:
https://doi.org/10.55640/eijmrms-06-06-13Keywords:
Osteoporosis, multiple myeloma, bone mineral densityAbstract
Osteoporosis is one of the most common and clinically significant complications of multiple myeloma (MM), substantially increasing the risk of pathological fractures and adversely affecting patients’ quality of life. Over the past decade, diagnostic strategies for skeletal involvement in MM have evolved due to the implementation of highly sensitive imaging modalities and quantitative techniques for assessing bone mineral density. This review summarizes contemporary approaches to the diagnosis of osteoporosis in patients with MM, evaluates their diagnostic performance, strengths, and limitations, and discusses emerging perspectives related to radiomics and artificial intelligence. Emphasis is placed on the importance of a comprehensive and multidisciplinary approach to skeletal assessment in this complex patient population.
References
Atypon. Bones in Multiple Myeloma: Imaging and Therapy. Review. Bone disease is frequent in MM and imaging plays a major role in disease management. PubMed. 2018;90% patients develop bone lesions.
Haemato radiology: the role of the radiologist at MDT. Br J Radiol. 2024;97(1163):1725–1735.
Modern imaging techniques for monitoring patients with multiple myeloma. Am J Nucl Med Mol Imaging. 2024;14(4):208–229.
Modern imaging techniques for monitoring patients with multiple myeloma. PubMed. 2024.
Imaging of Multiple Myeloma: Present and Future. PMC.
Role of Imaging in Multiple Myeloma: Quantitative Imaging and Radiomics? PMC.
Comparative evaluation of multiparametric lumbar MRI radiomic models for detecting osteoporosis. BMC Musculoskelet Disord. 2024;25:185.
Hybrid transformer convolutional neural network based radiomics models for osteoporosis screening in routine CT. BMC Med Imaging. 2024;24:62.
Li WG, Zeng R, Lu Y, et al. The value of radiomics based CT combined with machine learning in diagnosis of occult vertebral fractures. BMC Musculoskelet Disord. 2023;24:819.
International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20(6):e302–e312.
Zamagni E, Tacchetti P, Cavo M. Imaging in multiple myeloma: how? when? Blood. 2019;133(7):644–651.
Terpos E, Zamagni E, Lentzsch S, et al. Treatment of multiple myeloma–related bone disease: recommendations from IMWG. Lancet Oncol. 2021;22(3):e119–e130.
Messina C, Lastella G, Sorce C, et al. Artificial intelligence for osteoporosis detection and bone quality assessment: a systematic review. Eur Radiol. 2021;31(9):6786–6801.
Wang L, Wang Y, Guo Y, et al. Radiomics analysis of CT images for osteoporosis screening. Eur Radiol. 2020;30(12):6780–6788.
Rajkumar SV, Kumar S. Multiple myeloma: 2021 update on diagnosis, risk stratification and management. Am J Hematol. 2021;96(12):1455–1470.
Terpos E, Christoulas D, Kastritis E, et al. Current treatment and diagnostic strategies for myeloma related bone disease. Leukemia. 2020;34:3077–3092.
Roodman GD. Pathogenesis of myeloma bone disease: 2020 update. Curr Opin Hematol. 2020;27(4):234–242.
Storti P, Zamagni E, Cavo M. Imaging in multiple myeloma: recent advances. Hematol Oncol. 2021;39(5):689–701.
Multiple myeloma overview. MSD Manual Professional. 2024.
Amadori D, et al. Modern imaging and monitoring multiple myeloma patients: review. J Bone Oncol. 2025;51:100669.
Adams JE, Engelke K, Zemel BS, et al. Quantitative computed tomography in osteoporosis research and clinical practice. Osteoporos Int. 2018;29(1):1–26.
Schousboe JT, Shepherd JA, Bilezikian JP, et al. Executive summary of the 2013 ISCD position development conference on bone densitometry. J Clin Densitom. 2013;16(4):455–466.
Dieckmeyer M, Ruschke S, Cordes C, et al. Quantitative MRI for assessment of bone marrow fat and its role in osteoporosis and myeloma. J Magn Reson Imaging. 2017;45(2):423–437.
Pisani P, Renna MD, Conversano F, et al. Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop. 2016;7(3):171–181.
Cortet B, Lucas S, Legroux Gerot I, et al. Bone densitometry and secondary osteoporosis. Joint Bone Spine. 2019;86(2):145–151.
Guglielmi G, Muscarella S, Bazzocchi A. Integrated imaging approach to osteoporosis and bone fragility. Radiol Clin North Am. 2022;60(4):645–660.
Liu Z, Liu Z, Li H, et al. Radiomics in osteoporosis: from research to clinical practice. Quant Imaging Med Surg. 2021;11(9):3991–4005.
Yang L, Chen H, Zhang H, et al. Quantitative CT and DXA in bone mineral density assessment in multiple myeloma. BMC Musculoskelet Disord. 2022;23:134.
Wang M, Zhang Y, Li Y, et al. Machine learning for prediction of osteoporosis in hematologic malignancies: a radiomics study. Comput Biol Med. 2022;147:105768.
Zanghì A, Romano A, Rocca B, et al. Whole body low dose CT in the management of myeloma related bone disease: review and perspectives. Clin Imaging. 2021;73:29–36.
Wu X, Huang W, Zhang H, et al. Low dose whole body CT vs conventional radiography in multiple myeloma: diagnostic accuracy and clinical impact. Cancer Imaging. 2020;20:50.
He C, Gao S, Li X, et al. MRI assessment of bone marrow involvement in multiple myeloma: update 2020. Hematol Oncol. 2020;38:513–523.
Zamagni E, Patriarca F, Nanni C, et al. PET/CT and MRI in evaluating minimal residual disease in multiple myeloma. Blood Cancer J. 2020;10:36.
Sachpekidis C, Goldschmidt H, Edenbrandt L, et al. Radiomics and artificial intelligence landscape for 18F-FDG PET/CT in multiple myeloma. Semin Nucl Med. 2024.
Chugaev AI, Vasilev YA, et al. Application of radiomics in osteoporosis detection — current capabilities and future prospects. Digital Diagnostics. 2025;6(1):63–77.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gulchekhra Z. Mahamadaliyeva, Sitora. A. Istamova Radiologist, Xudoyberdi T. Zuhriddinov

This work is licensed under a Creative Commons Attribution 4.0 International License.
Individual articles are published Open Access under the Creative Commons Licence: CC-BY 4.0.